$EYPT stock has now risen 14% today, according to our price data from Polygon. There has been approximately $24,473,415 of trading volume.
Here is what we see in our data on $EYPT (you can track the company live on Quiver's $EYPT stock page):
$EYPT Insider Trading Activity
$EYPT insiders have traded $EYPT stock on the open market 3 times in the past 6 months. Of those trades, 0 have been purchases and 3 have been sales.
Here’s a breakdown of recent trading of $EYPT stock by insiders over the last 6 months:
- RAMIRO RIBEIRO (Chief Medical Officer) sold 2,722 shares for an estimated $31,602
- NANCY LURKER has made 0 purchases and 2 sales selling 700 shares for an estimated $10,465.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$EYPT Hedge Fund Activity
We have seen 69 institutional investors add shares of $EYPT stock to their portfolio, and 89 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- RA CAPITAL MANAGEMENT, L.P. removed 3,181,818 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $29,940,907
- PARADIGM BIOCAPITAL ADVISORS LP added 2,005,365 shares (+inf%) to their portfolio in Q3 2025, for an estimated $28,556,397
- ORBIMED ADVISORS LLC added 1,796,000 shares (+inf%) to their portfolio in Q3 2025, for an estimated $25,575,040
- PERCEPTIVE ADVISORS LLC removed 1,537,274 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $14,465,748
- ADAGE CAPITAL PARTNERS GP, L.L.C. removed 1,240,218 shares (-18.2%) from their portfolio in Q3 2025, for an estimated $17,660,704
- FINEPOINT CAPITAL LP removed 1,081,954 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $10,181,187
- BALYASNY ASSET MANAGEMENT L.P. added 756,087 shares (+inf%) to their portfolio in Q3 2025, for an estimated $10,766,678
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$EYPT Analyst Ratings
Wall Street analysts have issued reports on $EYPT in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Chardan Capital issued a "Buy" rating on 08/07/2025
- RBC Capital issued a "Outperform" rating on 06/17/2025
To track analyst ratings and price targets for $EYPT, check out Quiver Quantitative's $EYPT forecast page.
$EYPT Price Targets
Multiple analysts have issued price targets for $EYPT recently. We have seen 3 analysts offer price targets for $EYPT in the last 6 months, with a median target of $27.0.
Here are some recent targets:
- Lisa Walter from RBC Capital set a target price of $39.0 on 11/06/2025
- Daniil Gataulin from Chardan Capital set a target price of $27.0 on 08/07/2025
- Yi Chen from HC Wainwright & Co. set a target price of $23.0 on 08/06/2025
You can track data on $EYPT on Quiver Quantitative.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
